Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells - Wikidata - wikimedia - TriplyDB

Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells

Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells

http://www.wikidata.org/entity/Q33664289

about

Prohibitins role in cellular survival through Ras-Raf-MEK-ERK pathway Microtubule-binding agents: a dynamic field of cancer therapeutics.Multifaceted role of prohibitin in cell survival and apoptosis Induction of paclitaxel resistance by ERα mediated prohibitin mitochondrial-nuclear shuttling Hybrid lipid-polymer nanoparticles for sustained siRNA delivery and gene silencing.Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice miR-17-5p downregulation contributes to paclitaxel resistance of lung cancer cells through altering beclin1 expression Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment.Tubulin Beta3 Serves as a Target of HDAC3 and Mediates Resistance to Microtubule-Targeting Drugs.The role and therapeutic potential of prohibitin in disease.Multifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer Therapy.Casein kinase I epsilon interacts with mitochondrial proteins for the growth and survival of human ovarian cancer cells.Artemin stimulates radio- and chemo-resistance by promoting TWIST1-BCL-2-dependent cancer stem cell-like behavior in mammary carcinoma cells.Targeted gene delivery to ischemic myocardium by homing peptide-guided polymeric carrier miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo Comparative Proteomic Analysis of Advanced Ovarian Cancer Tissue to Identify Potential Biomarkers of Responders and Nonresponders to First-Line Chemotherapy of Carboplatin and Paclitaxel.Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET.Differential expression and subcellular localization of Prohibitin 1 are related to tumorigenesis and progression of non-small cell lung cancer Advances in the proteomic discovery of novel therapeutic targets in cancer.Multiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulation Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma Bisdemethoxycurcumin exerts pro-apoptotic effects in human pancreatic adenocarcinoma cells through mitochondrial dysfunction and a GRP78-dependent pathway.Lipid rafts: signaling and sorting platforms of cells and their roles in cancer.Tumour endothelial cells acquire drug resistance in a tumour microenvironment.Identification of prohibitin 1 as a potential prognostic biomarker in human pancreatic carcinoma using modified aqueous two-phase partition system combined with 2D-MALDI-TOF-TOF-MS/MS.Anti-angiogenic nanotherapy via active targeting systems to tumors and adipose tissue vasculature.MicroRNA-26a promotes tumor growth and angiogenesis in glioma by directly targeting prohibitin.Mitochondrial-nuclear communication by prohibitin shuttling under oxidative stress.Assessment of flavaglines as potential chikungunya virus entry inhibitors.Oligopeptide complex for targeted non-viral gene delivery to adipocytes.Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.The prohibitin protein complex promotes mitochondrial stabilization and cell survival in hematologic malignancies 4th international conference on tumor progression and therapeutic resistance: meeting report.Cytokine-Induced Killer Cells Modulates Resistance to Cisplatin in the A549/DDP Cell Line.MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1.Proteomic analysis of mitochondria: biological and clinical progresses in cancer.A Naturally Generated Decoy of the Prostate Apoptosis Response-4 Protein Overcomes Therapy Resistance in Tumors.Paclitaxel treatment and PC1/3 knockdown in macrophages is a promising anti-glioma strategy as revealed by proteomics and cytotoxicity studies.Synergistic Anticancer Effect of Paclitaxel and Noscapine on Human Prostate Cancer Cell Lines.Raf activation by Ras and promotion of cellular metastasis require phosphorylation of prohibitin in the raft domain of the plasma membrane.

P2860

Q26859864-AEA25767-85C0-4E97-9FFC-9C147BBA379E Q27690249-9B327F6C-00C3-4552-B985-6C27C1AFF7A7 Q28087391-F7000997-651D-487E-9483-1BA369A6E36C Q28537899-B51C676B-B801-427E-8F27-BBE116C939EE Q33831440-3B5B418F-7341-4A9B-B699-4CC3E14F662C Q34420616-2582BE93-8680-467A-A37F-FF9C88705ADF Q35154831-0B056F05-73D6-4CA5-8A29-D854DC183C00 Q35796255-4E43DD90-D8D1-4391-914C-19BA749B579A Q35988876-2B10B265-8123-4C48-8900-32D8C3B5C0E3 Q36018450-B4F6C6AC-A515-4CFD-B7FE-8B00B5B7CC3C Q36291372-09582BBE-1915-4A43-BA07-67D30720409F Q36379515-0FDA5655-07D4-4AA4-865E-9645588981DF Q36466583-B953CFD6-374C-4B90-88BA-90F05FF06BE4 Q36525748-5215C506-ADA9-4870-99D2-D9CE26AAE9C6 Q36610611-CF9A65F1-5B5C-4746-BEA6-7BE497EE2DD0 Q36696710-5D9810EF-E288-45A1-A9E7-5FE24207A5FB Q36809577-B608B2FF-DA36-4FE8-93E5-142094C2BDFF Q37228835-72BBA2E6-5FFB-4E43-8D20-C85BD016B4B9 Q37260569-090B079D-0ECA-4548-A493-69175BD0B9FB Q37376285-2B17C4F5-3948-4A5D-93DF-1F2357D028B0 Q37609193-F11980A9-0149-42B3-B190-0C5E675E0933 Q37696356-39ECBA1E-2E36-4C0E-B067-CAD1AE116AB6 Q37866316-0BA6021F-3E26-4086-BE93-6E64200E6ABC Q38072018-15B98B30-8A6C-4FE8-998A-78355FF75CB2 Q38471197-18CAF1FA-A2F8-4815-8F54-69FADE6D057F Q38564219-629ACCF7-9488-4F15-B7AE-234C69D74048 Q39123359-CFE3FAF1-0977-44B8-9744-C91D1ACE79D9 Q39481814-AB6D00A9-6F46-4CD5-9C70-FA38AE9D94B9 Q40171382-ED17FA6F-76F1-4376-B4AD-164CB38362AE Q42184688-5953373B-20EC-4030-94B0-27B1164A7DBA Q42336467-8FDB4D67-60F2-4758-B657-E806C7E8DF4B Q42371544-1BA4E380-AEA9-4AFD-9E02-7829990568AC Q43200018-17EB0E69-0AE9-454F-8B7B-98308AF98A91 Q46028686-46E1D9ED-9765-443C-B018-CBE410E16490 Q47616712-9E20FC53-88A4-4C77-B44B-14EA2D3D508D Q47729926-CAC220C6-1E51-437D-816B-64F732AE478B Q50938497-879A2461-BF6F-443D-9832-BE5A938A428D Q52659651-ACE78F5D-0ADF-4538-85F5-C4F93287CAE6 Q53701201-A9C9A625-87A1-4C89-AF99-F41086F71B91 Q54524045-487B7FFF-28CC-45D7-93C0-46FE4EA3C47C

P2860

Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells

http://www.wikidata.org/entity/Q33664289

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Rescue of paclitaxel sensitivi ...... in drug-resistant cancer cells

@ast

Rescue of paclitaxel sensitivi ...... in drug-resistant cancer cells

@en

type

label

Rescue of paclitaxel sensitivi ...... in drug-resistant cancer cells

@ast

Rescue of paclitaxel sensitivi ...... in drug-resistant cancer cells

@en

prefLabel

Rescue of paclitaxel sensitivi ...... in drug-resistant cancer cells

@ast

Rescue of paclitaxel sensitivi ...... in drug-resistant cancer cells

@en

P1433

Q33664289-84A511D2-C8CE-4521-89FB-4E3C966DAC48

P1476

Q33664289-745472E7-C621-4ED4-ADA6-106158EDCAE2

P2093

Q33664289-17F758FF-DD9E-4DA3-A2C2-C898C5F8EC7B

Q33664289-340FB54A-B562-4D11-81DB-D093E3623C92

Q33664289-3B2B3FF0-FA80-47F7-950A-E798672272F3

Q33664289-407122DC-15EC-4B18-987A-B36B9932FBFE

Q33664289-7E56683E-4B2C-4A89-8920-593F16F875AE

Q33664289-90DF8E60-B754-4EF3-A337-6DA4A26D72EE

Q33664289-B968AAEC-1062-4E3D-B295-86BC2A81E9A0

Q33664289-CE6A523F-CE7F-4D53-BE59-3A35450E9220

P2860

Q33664289-03EBFADD-9CAA-4FFC-AC1A-1740136EEEFB

Q33664289-09C569FC-10B7-4CB4-A296-DBCB465CB190

Q33664289-0A1ABB72-20AE-4DE1-80C3-960B8560ACBD

Q33664289-1F431450-68AD-48D5-BF23-F49CAC4A8CA6

Q33664289-1FF89A00-CB3F-4390-97B5-C99D58197722

Q33664289-26AB290D-086E-4285-BF74-33D9D4737A28

Q33664289-2C97678F-393D-4CCA-8F41-27A1BE6F4E76

Q33664289-316C36A2-617A-40D1-B963-498DDD12ADC2

Q33664289-3626EC74-DD63-47EC-9C2B-348B8EB1400E

Q33664289-48E08686-67A9-4B9E-8C9D-3471B8BFE8B8

P304

Q33664289-51CB6897-0D8F-413B-81FA-E506D9866D80

P31

Q33664289-C23D4974-E4CA-4339-9553-82E6BD2CCB5B

P356

Q33664289-E33EADB4-3620-471E-9ACA-525BF370D7E6

P407

Q33664289-B35548AA-DACE-4146-9627-4D483D459F19

P433

Q33664289-D8C4F7BE-7266-41A1-89E9-00FEBD200BF6

P478

Q33664289-B9178402-783B-4892-9EB5-74C27A73085B

P577

Q33664289-642BF5E6-2727-4C7F-8BF0-D6DA49B5CB57

P5875

Q33664289-743005CC-3F50-440F-AF84-47E4C6E6D23C

P698

Q33664289-2623ED55-5C78-41A6-B720-14ACFB9A34C4

P932

Q33664289-DFBDDDD1-B4CE-4B62-A317-8686CE254716

P356

PNAS.0910649107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Rescue of paclitaxel sensitivi ...... in drug-resistant cancer cells

@en

P2093

Bruce R Zetter

http://www.w3.org/2001/XMLSchema#string

Carol Waghorne

http://www.w3.org/2001/XMLSchema#string

Chunyao Jenny Mu

http://www.w3.org/2001/XMLSchema#string

Ivy Chung

http://www.w3.org/2001/XMLSchema#string

Nish Patel

http://www.w3.org/2001/XMLSchema#string

Rachelle R Olsen

http://www.w3.org/2001/XMLSchema#string

Sabarni K Chatterjee

http://www.w3.org/2001/XMLSchema#string

Vladimir Vrbanac

http://www.w3.org/2001/XMLSchema#string

P2860

Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence

Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling

Camptothecin induces nuclear export of prohibitin preferentially in transformed cells through a CRM-1-dependent mechanism

Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression

The phagosome proteome: insight into phagosome functions

Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins.

Mechanisms of caspase activation

Prohibitin: a potential target for new therapeutics

Prohibitin: potential role in senescence, development, and tumor suppression

The 3' untranslated region of prohibitin and cellular immortalization

P304

2503-2508

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0910649107

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41408652

http://www.w3.org/2001/XMLSchema#string

P698

20133800

http://www.w3.org/2001/XMLSchema#string

P932

2823873

http://www.w3.org/2001/XMLSchema#string